Andreas Fibig to Leave Bayer HealthCare
Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, will leave the company to become CEO of International Flavors & Fragrances on Sept. 1, 2014. Bayer said it would nominate a successor shortly.
Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, will leave the company to become CEO of International Flavors & Fragrances on Sept. 1, 2014. Bayer said it would nominate a successor shortly.

BASF sells a majority stake in its coatings business to the investor Carlyle.

Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.


Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.

Ineos CEO Ineos calls on European politicians to save the chemical industry.